Martin Kreller

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Molecularly Imprinted

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Santiago Andrés Brühlmann, Martin Walther, Martin Kreller, Falco Reissig, Hans-Jürgen Pietzsch, Torsten Kniess, Klaus Kopka
Cyclotron-Based Production of 67 Cu for Radionuclide Theranostics via the 70 Zn(p,α) 67 Cu Reaction. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Santiago Andrés Brühlmann, Martin Kreller, Hans-Jürgen Pietzsch, Klaus Kopka, Constantin Mamat, Martin Walther, Falco Reissig
Efficient Production of the PET Radionuclide 133 La for Theranostic Purposes in Targeted Alpha Therapy Using the 134 Ba(p,2n) 133 La Reaction. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Falco Reissig, David Bauer, Martin Ullrich, Martin Kreller, Jens Pietzsch, Constantin Mamat, Klaus Kopka, Hans-Jürgen Pietzsch, Martin Walther
Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging. Pharmaceuticals (Basel, Switzerland) 13 (10) (2020)